Hemorrhagic Shock Clinical Trial
Official title:
Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis
In this study the impact of two CE marked and FDA approved sternal needles in comparison to intravenous access on the flow-rate of autologous reinfusion of whole blood and the possible hemolysis of red cells post-transfusion in a population of healthy military officers is investigated.
Intraosseous (IO) access is an old technique for achieving entrance to the systemic
circulation, which has gained resurgence in the last 30 years.
Whether due to trauma or disease, vascular collapse may delay or preclude even experienced
medical providers from obtaining standard intravenous (IV) access. Access to the vascular
system of the critically ill or injured adult or pediatric patient is essential for
resuscitation, and flow rates close up to what can be obtained by using intravenous access is
preferable in patient needing immediate fluid boluses for shock resuscitation. Intraosseous
access takes advantage of the vascularity of cancellous bone, the spongy bone inside the
hard, and access to the highly vascular intramedullary space of bones provides a direct link
to central circulation. In addition to using long bones, the sternum is used for intraosseous
access and has gained increased use especially in combat casualty care.
However, in a recent publication, the intraosseous route used for transfusion of blood
components is questioned. Based on theoretical models for flow rates through porous media and
personal clinical observations the authors conclude that the maximum flow rates attainable
for transfusion of blood via intraosseous route are inadequate for successful resuscitation.
They also fear that additional pressure needed to obtain adequate flow rate may cause
hemolysis of red blood cells. Further they postulate that as the bone mineral density reaches
a peak occurring in the early 20s, and that a small increase in bone density may cause
exponential decrease in intrinsic permeability, there could be a 10-fold decrease in
permeability in military age causalities compared to the elderly. The critical points
highlighted in this review are in great contrast to recent experience with the use of sternal
and humeral I.O`s in Operation Enduring Freedom (OEF).
This observational study investigates the impact of two CE marked and FDA approved sternal
needles in comparison to intravenous access on the flow-rate of autologous reinfusion of
whole blood and the possible hemolysis of red cells post-transfusion in a population of
healthy military officers. We also investigate the technical success rate of sternal IO
Access between two CE marked and FDA approved sternal Devices. As a supplementary
investigation we seek to investigate the anatomic changes as shown by Magnetic Resonance
Imaging in individuals who have received multiple intraosseous sternal needles With
autologous reinfusion of whole blood.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04149171 -
Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage
|
Phase 3 | |
Not yet recruiting |
NCT06070350 -
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
|
Phase 3 | |
Not yet recruiting |
NCT02880163 -
REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam
|
N/A | |
Terminated |
NCT00750997 -
Hypertonic Modulation of Inflammation Following Injury
|
N/A | |
Terminated |
NCT03477006 -
Pragmatic Prehospital Group O Whole Blood Early Resuscitation Trial
|
Phase 3 | |
Not yet recruiting |
NCT04987411 -
Detection of Exhaled Methane Levels in Hemorrhagic Shock
|
||
Recruiting |
NCT04610814 -
Blood Transfusion by Boston MedFlight Registry
|
||
Completed |
NCT02071290 -
Effect of Remote Ischemic Conditioning on Trauma Patients With Hemorrhagic Shock
|
N/A | |
Completed |
NCT03535441 -
HMGB1 Release From Hemorrhagic Shock Patients
|
||
Completed |
NCT03480555 -
Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients
|
N/A | |
Completed |
NCT03402035 -
Shock, Whole Blood, and Assessment of TBI S.W.A.T. (LITES TO 2)
|
||
Completed |
NCT05081063 -
Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients
|
Phase 3 | |
Recruiting |
NCT03235921 -
Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock
|
Phase 2 | |
Active, not recruiting |
NCT03469947 -
California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA
|
Phase 3 | |
Completed |
NCT01411852 -
Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma
|
Phase 2 | |
Withdrawn |
NCT01221389 -
Study Using Plasma for Patients Requiring Emergency Surgery
|
Phase 4 | |
Recruiting |
NCT03406598 -
Bedside Visual Analysis of Sublingual Microcirculation in Shock Patients
|
||
Completed |
NCT00328133 -
The Use of rFVIIa in Trauma Patients: A Multi-Center Case Registry
|
N/A | |
Completed |
NCT00379522 -
Vasopressin in Traumatic Hemorrhagic Shock Study
|
Phase 2/Phase 3 | |
Completed |
NCT00945542 -
The Trauma- Formula-Driven Versus Lab-Guided Study (TRFL Study)
|
Phase 1/Phase 2 |